<DOC>
	<DOCNO>NCT02395978</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy patient major depressive disorder .</brief_summary>
	<brief_title>A Phase II Study PDC-1421 Capsule Evaluate Safety Efficacy Patients With Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>1 . Outpatients age 2065 year 2 . Subjects must able understand willing sign inform consent 3 . Female subject childbearing potential must test negative pregnancy use appropriate birth control method begin study 15 day later end study 4 . Met criterion MDD without psychotic feature define Diagnostic Statistical Manual Mental Disorders , Fourth Edition Text Revision® ( DSMIVTR ) confirm use Mini International Neuropsychiatric Interview ( MINI ) . 5 . 17item HAMD ( Hamilton Rating Scale Depression ) total score ≧20 CGI ( Clinical Global Impression ) total score ≧4 1 . Have current previous major psychiatric disorder define per DSMIVTR , include obsessivecompulsive disorder , posttraumatic stress disorder , bipolar I II , manic hypomanic episode , schizophrenia , major Axis II disorder might compromise study , major depression psychotic symptom , mental retardation . 2 . Use treatment MDD last 2 week visit 1 ( 4 week fluoxetine ) . 3 . Use psychoactive drug within last 2 week visit 1 subject insomnia need treatment determine Investigator . 4 . Subjects nonresponsive two course antidepressant medication give adequate dosage symptom treatment within four week , judgment investigator consider treatment resistant depression ( TRD ) , history electroconvulsive therapy ( ECT ) , transcranial magnetic stimulation ( TMS ) psychosurgery within last year . 5 . Have history seizure disorder . 6 . Any clinically significant abnormal vital sign , ECG , laboratory value determine investigator might interfere study . 7 . Any organic disorder cause u medical relate depression wellcontrolled clinically significant neurological , gastrointestinal , renal , hepatic , cardiovascular , respiratory , metabolic , endocrine , hematological major disorder 8 . Have high suicidal risk measure MINI . 9 . Have history substance abuse within past 6 month positive urine drug screen substance abuse visit 1 . 10 . Have history severe allergies 1 class medication multiple adverse drug reaction .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>